EUROPEAN MARKETS FOR STENTS IN PERIPHERAL VASCULAR APPLICATIONS

345 Pages | 109 Exhibits | 2005 Analysis | Forecasts Through 2011 Product Family: Market Reports




OVERVIEW:
In 2004, the European peripheral vascular stents market was valued at approximately $306.1 million. Over the forecast period covered by this report, sales are expected to increase at a compound annual rate of 8.4%, reaching approximately $538.5 million in the year 2011. Market drivers include the aging of the population, improved screening and detection of peripheral vascular disease, technological advances, and a shift from lower-priced plastic stents to higher-priced metal stents.

This 345-page report from Medtech Insight includes analyses of products, technologies, current and forecast markets, competitors, and opportunities in the European peripheral vascular stents market.

Topics discussed in this report include a detailed discussion of European healthcare systems, a description of peripheral vascular diseases and treatments, abdominal aortic aneurysm stent-grafts, carotid artery stents, femoropopliteal artery stents, iliac artery stents, renal artery stents, and transjugular intrahepatic portosystemic shunts. Countries covered by this report include France; Germany; Italy; Spain; the United Kingdom; the Benelux countries of Belgium, the Netherlands, and Luxembourg; and the Nordic countries of Denmark, Finland, Iceland, Norway, and Sweden.

TABLE OF CONTENTS:

EXECUTIVE SUMMARY

i. Methodology Statement

ii. European Peripheral Vascular Stents Market

a. Iliac Artery Stents

b. Femoropopliteal Artery Stents

c. Transjugular Intrahepatic Portosystemic Shunts

d. Renal Artery Stents

e. Abdominal Aortic Aneurysm Stent-Grafts

f. Carotid Artery Stents

g. Market Forecast

h. Market Drivers

i. Market Limiters

Exhibit ES-1: Europe, Peripheral Vascular Stents, Market Forecast, 2004-2011

Exhibit ES-2: Europe, Peripheral Vascular Stents, Market Forecast, by Country, 2004-2011

1. EUROPEAN HEALTHCARE MARKET OVERVIEW

1.1 The European Union

1.1.1 A Common Currency

1.1.2 Regulatory Policies

1.1.3 Reimbursement

1.1.4 Healthcare Spending

1.2 National Profiles

1.2.1 France

1.2.1.1 Healthcare Organization and Reform

1.2.1.2 Hospital Services

1.2.1.3 Medical Device Reimbursement

1.2.2 Germany

1.2.2.1 Healthcare Organization and Reform

1.2.2.2 Hospital Services

1.2.2.3 Medical Device Reimbursement

1.2.3 Italy

1.2.3.1 Healthcare Organization and Reform

1.2.3.2 Hospital Services

1.2.3.3 Medical Device Reimbursement

1.2.4 Spain

1.2.4.1 Healthcare Organization and Reform

1.2.4.2 Hospital Services

1.2.4.3 Medical Device Reimbursement

1.2.5 United Kingdom

1.2.5.1 Healthcare Organization and Reform

1.2.5.2 Hospital Services

1.2.5.3 Medical Device Reimbursement

1.2.6 Benelux Countries

1.2.6.1 Healthcare Organization and Reform

1.2.6.2 Hospital Services

1.2.6.3 Medical Device Reimbursement

1.2.7 Nordic Countries

1.2.7.1 Healthcare Organization and Reform

1.2.7.1.1 Denmark

1.2.7.1.2 Finland

1.2.7.1.3 Iceland

1.2.7.1.4 Norway

1.2.7.1.5 Sweden

1.2.7.2 Hospital Services

1.2.7.2.1 Denmark

1.2.7.2.2 Finland

1.2.7.2.3 Iceland

1.2.7.2.4 Norway

1.2.7.2.5 Sweden

1.2.7.3 Medical Device Reimbursement

1.2.7.3.1 Denmark

1.2.7.3.2 Finland

1.2.7.3.3 Iceland

1.2.7.3.4 Norway

1.2.7.3.5 Sweden

Exhibit 1-1: European Union, Medical Devices Risk Classification System

Exhibit 1-2: European Union, Population Statistics Comparison, 1994 and 2004

Exhibit 1-3: France, Selected National Healthcare Statistics

Exhibit 1-4: Germany, Selected National Healthcare Statistics

Exhibit 1-5: Italy, Selected National Healthcare Statistics

Exhibit 1-6: Spain, Selected National Healthcare Statistics

Exhibit 1-7: United Kingdom, Selected National Healthcare Statistics

Exhibit 1-8: Belgium, Selected National Healthcare Statistics

Exhibit 1-9: Netherlands, Selected National Healthcare Statistics

Exhibit 1-10: Luxembourg, Selected National Healthcare Statistics

Exhibit 1-11: Denmark, Selected National Healthcare Statistics

Exhibit 1-12: Finland, Selected National Healthcare Statistics

Exhibit 1-13: Iceland, Selected National Healthcare Statistics

Exhibit 1-14: Norway, Selected National Healthcare Statistics

Exhibit 1-15: Sweden, Selected National Healthcare Statistics

2. OVERVIEW OF STENTING FOR PERIPHERAL VASCULAR APPLICATIONS

2.1 Cardiovascular Disease

2.1.1 Incidence and Prevalence

2.2 Peripheral Vascular Disease

2.2.1 Peripheral Artery Disease

2.2.1.1 Carotid Artery Disease

2.2.1.2 Lower-Extremity Peripheral Artery Disease

2.2.1.3 Mesenteric Artery Disease

2.2.1.4 Renal Artery Stenosis

2.2.1.5 Aneurysm

2.2.1.5.1 Abdominal Aortic Aneurysm

2.2.1.6 Other Peripheral Artery Diseases

2.2.2 Peripheral Venous Disorders

2.2.2.1 Chronic Venous Insufficiency

2.2.2.2 Thrombophlebitis

2.2.2.3 Varicose Veins

2.2.3 Causes

2.2.3.1 Atherosclerosis

2.2.3.1.1 Incidence and Prevalence

2.2.3.1.2 Treatment

2.2.3.2 Hypertension

2.2.3.2.1 Incidence and Prevalence

2.2.3.2.2 Treatment

2.2.3.3 Diabetes

2.2.3.3.1 Type 1 Diabetes

2.2.3.3.2 Type 2 Diabetes

2.2.3.3.3 Macrovascular Disease

2.2.3.3.4 Hyperglycemia and Atherosclerosis

2.2.3.3.5 Hyperinsulinemia and Atherosclerosis

2.2.3.3.6 Incidence and Prevalence

2.2.4 Nonsurgical Treatment

2.2.4.1 Hypertension

2.2.4.1.1 Pharmaceuticals

2.2.4.2 Diabetes

2.2.4.2.1 Pharmaceuticals

2.2.5 Surgical Treatment

2.2.5.1 Ablative Laser-Assisted Angioplasty

2.2.5.2 Bypass Grafting Surgery

2.2.5.3 Catheter-Based Thrombolysis and Mechanical Thrombectomy

2.2.5.4 CryoPlasty

2.2.5.5 Endarterectomy

2.2.5.6 Percutaneous Transluminal Angioplasty

2.2.5.7 Peripheral Atherectomy

2.2.5.8 Vascular Brachytherapy

2.2.5.9 Intravascular Stenting

2.2.5.9.1 Drug-Eluting Stents

2.2.5.9.1.1 ABT-578-Eluting

2.2.5.9.1.2 AP23573-Eluting

2.2.5.9.1.3 Biolimus A9-Eluting

2.2.5.9.1.4 Everolimus-Eluting

2.2.5.9.1.5 Paclitaxel-Eluting

2.2.5.9.1.6 Sirolimus-Eluting

2.2.5.9.1.7 Tacrolimus-Eluting

Exhibit 2-1: 2004, Europe, Cardiovascular Disease-Related Deaths, by Country

Exhibit 2-2: Peripheral Arteries

Exhibit 2-3: Arteries of the Head and Neck

Exhibit 2-4: Arteries of the Lower Body

Exhibit 2-5: Classification of Abdominal Aortic Aneurysms

Exhibit 2-6: 2002, Deaths Due to Ischemic Heart Disease, by Country

Exhibit 2-7: 2004, Systolic Blood Pressure Levels in Selected European Countries

Exhibit 2-8: Prevalence of Diabetes, by Country, 2003 and 2025

3. THE EUROPEAN PERIPHERAL VASCULAR STENTS MARKET

3.1 Market Drivers

3.2 Market Limiters

3.3 Market Analysis

3.3.1 Market Forecast, by Country

3.3.1.1 France

3.3.1.2 Germany

3.3.1.3 Italy

3.3.1.4 Spain

3.3.1.5 United Kingdom

3.3.1.6 Benelux Countries

3.3.1.7 Nordic Countries

3.3.1.8 Rest-of-Europe

3.3.2 Competitive Analysis

3.4 Iliac Artery Stents

3.4.1 Products

3.4.1.1 Balloon-Expanded Stents

3.4.1.2 Self-Expanding Stents

3.4.1.3 Covered Stents

3.4.2 Market Analysis

3.4.2.1 Market Forecast, by Country

3.4.2.2 Competitive Analysis

3.5 Femoropopliteal Stents

3.5.1 Products

3.5.2 Clinical Trials

3.5.3 Market Analysis

3.5.3.1 Market Forecast, by Country

3.5.3.2 Competitive Analysis

3.6 Transjugular Intrahepatic Portosystemic Shunts

3.6.1 Products

3.6.2 Market Analysis

3.6.2.1 Market Forecast, by Country

3.6.2.2 Competitive Analysis

3.7 Renal Artery Stents

3.7.1 Products

3.7.2 Clinical Trials

3.7.3 Market Analysis

3.7.3.1 Market Forecast, by Country

3.7.3.2 Competitive Analysis

3.8 Abdominal Aortic Aneurysm Stent-Grafts

3.8.1 Products

3.8.2 Market Analysis

3.8.2.1 Market Forecast, by Country

3.8.2.2 Competitive Analysis

3.9 Carotid Artery Stents

3.9.1 Products

3.9.2 Market Analysis

3.9.2.1 Market Forecast, by Country

3.9.2.2 Competitive Analysis

Exhibit 3-1: Europe, Peripheral Vascular Stents, Market Forecast, 2004-2011

Exhibit 3-2: France, Peripheral Vascular Stents, Market Forecast, 2004-2011

Exhibit 3-3: Germany, Peripheral Vascular Stents, Market Forecast, 2004-2011

Exhibit 3-4: Italy, Peripheral Vascular Stents, Market Forecast, 2004-2011

Exhibit 3-5: Spain, Peripheral Vascular Stents, Market Forecast, 2004-2011

Exhibit 3-6: United Kingdom, Peripheral Vascular Stents, Market Forecast, 2004-2011

Exhibit 3-7: Benelux Countries, Peripheral Vascular Stents, Market Forecast, 2004-2011

Exhibit 3-8: Nordic Countries, Peripheral Vascular Stents, Market Forecast, 2004-2011

Exhibit 3-9: Rest-of-Europe, Peripheral Vascular Stents, Market Forecast, 2004-2011

Exhibit 3-10: 2004, Europe, Peripheral Vascular Stents Market, Share by Supplier

Exhibit 3-11: 2004, France, Peripheral Vascular Stents Market, Share by Supplier

Exhibit 3-12: 2004, Germany, Peripheral Vascular Stents Market, Share by Supplier

Exhibit 3-13: 2004, Italy, Peripheral Vascular Stents Market, Share by Supplier

Exhibit 3-14: 2004, Spain, Peripheral Vascular Stents Market, Share by Supplier

Exhibit 3-15: 2004, United Kingdom, Peripheral Vascular Stents Market, Share by Supplier

Exhibit 3-16: 2004, Benelux Countries, Peripheral Vascular Stents Market, Share by Supplier

Exhibit 3-17: 2004, Nordic Countries, Peripheral Vascular Stents Market, Share by Supplier

Exhibit 3-18: 2004, Rest-of-Europe, Peripheral Vascular Stents Market, Share by Supplier

Exhibit 3-19: Europe, Iliac Artery Stents, Market Forecast, 2004-2011

Exhibit 3-20: France, Iliac Artery Stents, Market Forecast, 2004-2011

Exhibit 3-21: Germany, Iliac Artery Stents, Market Forecast, 2004-2011

Exhibit 3-22: Italy, Iliac Artery Stents, Market Forecast, 2004-2011

Exhibit 3-23: Spain, Iliac Artery Stents, Market Forecast, 2004-2011

Exhibit 3-24: United Kingdom, Iliac Artery Stents, Market Forecast, 2004-2011

Exhibit 3-25: Benelux Countries, Iliac Artery Stents, Market Forecast, 2004-2011

Exhibit 3-26: Nordic Countries, Iliac Artery Stents, Market Forecast, 2004-2011

Exhibit 3-27: Rest-of-Europe, Iliac Artery Stents, Market Forecast, 2004-2011

Exhibit 3-28: 2004, Europe, Iliac Artery Stents Market, Share by Supplier

Exhibit 3-29: Europe, Femoropopliteal Stents, Market Forecast, 2004-2011

Exhibit 3-30: France, Femoropopliteal Stents, Market Forecast, 2004-2011

Exhibit 3-31: Germany, Femoropopliteal Stents, Market Forecast, 2004-2011

Exhibit 3-32: Italy, Femoropopliteal Stents, Market Forecast, 2004-2011

Exhibit 3-33: Spain, Femoropopliteal Stents, Market Forecast, 2004-2011

Exhibit 3-34: United Kingdom, Femoropopliteal Stents, Market Forecast, 2004-2011

Exhibit 3-35: Benelux Countries, Femoropopliteal Stents, Market Forecast, 2004-2011

Exhibit 3-36: Nordic Countries, Femoropopliteal Stents, Market Forecast, 2004-2011

Exhibit 3-37: Rest-of-Europe, Femoropopliteal Stents, Market Forecast, 2004-2011

Exhibit 3-38: 2004, Europe, Femoropopliteal Stents Market, Share by Supplier

Exhibit 3-39: Europe, Transjugular Intrahepatic Portosystemic Shunts, Market Forecast, 2004-2011

Exhibit 3-40: France, Transjugular Intrahepatic Portosystemic Shunts, Market Forecast, 2004-2011

Exhibit 3-41: Germany, Transjugular Intrahepatic Portosystemic Shunts, Market Forecast, 2004-2011

Exhibit 3-42: Italy, Transjugular Intrahepatic Portosystemic Shunts, Market Forecast, 2004-2011

Exhibit 3-43: Spain, Transjugular Intrahepatic Portosystemic Shunts, Market Forecast, 2004-2011

Exhibit 3-44: United Kingdom, Transjugular Intrahepatic Portosystemic Shunts, Market Forecast, 2004-2011

Exhibit 3-45: Benelux Countries, Transjugular Intrahepatic Portosystemic Shunts, Market Forecast, 2004-2011

Exhibit 3-46: Nordic Countries, Transjugular Intrahepatic Portosystemic Shunts, Market Forecast, 2004-2011

Exhibit 3-47: Rest-of-Europe, Transjugular Intrahepatic Portosystemic Shunts, Market Forecast, 2004-2011

Exhibit 3-48: 2004, Europe, Transjugular Intrahepatic Portosystemic Shunts Market, Share by Supplier

Exhibit 3-49: Europe, Renal Artery Stents, Market Forecast, 2004-2011

Exhibit 3-50: France, Renal Artery Stents, Market Forecast, 2004-2011

Exhibit 3-51: Germany, Renal Artery Stents, Market Forecast, 2004-2011

Exhibit 3-52: Italy, Renal Artery Stents, Market Forecast, 2004-2011

Exhibit 3-53: Spain, Renal Artery Stents, Market Forecast, 2004-2011

Exhibit 3-54: United Kingdom, Renal Artery Stents, Market Forecast, 2004-2011

Exhibit 3-55: Benelux Countries, Renal Artery Stents, Market Forecast, 2004-2011

Exhibit 3-56: Nordic Countries, Renal Artery Stents, Market Forecast, 2004-2011

Exhibit 3-57: Rest-of-Europe, Renal Artery Stents, Market Forecast, 2004-2011

Exhibit 3-58: 2004, Europe, Renal Artery Stents Market, Share by Supplier

Exhibit 3-59: Europe, Abdominal Aortic Aneurysm Stent-Grafts, Market Forecast, 2004-2011

Exhibit 3-60: France, Abdominal Aortic Aneurysm Stent-Grafts, Market Forecast, 2004-2011

Exhibit 3-61: Germany, Abdominal Aortic Aneurysm Stent-Grafts, Market Forecast, 2004-2011

Exhibit 3-62: Italy, Abdominal Aortic Aneurysm Stent-Grafts, Market Forecast, 2004-2011

Exhibit 3-63: Spain, Abdominal Aortic Aneurysm Stent-Grafts, Market Forecast, 2004-2011

Exhibit 3-64: United Kingdom, Abdominal Aortic Aneurysm Stent-Grafts, Market Forecast, 2004-2011

Exhibit 3-65: Benelux Countries, Abdominal Aortic Aneurysm Stent-Grafts, Market Forecast, 2004-2011

Exhibit 3-66: Nordic Countries, Abdominal Aortic Aneurysm Stent-Grafts, Market Forecast, 2004-2011

Exhibit 3-67: Rest-of-Europe, Abdominal Aortic Aneurysm Stent-Grafts, Market Forecast, 2004-2011

Exhibit 3-68: 2004, Europe, Abdominal Aortic Aneurysm Stent-Grafts Market, Share by Supplier

Exhibit 3-69: Europe, Carotid Artery Stents, Market Forecast, 2004-2011

Exhibit 3-70: France, Carotid Artery Stents, Market Forecast, 2004-2011

Exhibit 3-71: Germany, Carotid Artery Stents, Market Forecast, 2004-2011

Exhibit 3-72: Italy, Carotid Artery Stents, Market Forecast, 2004-2011

Exhibit 3-73: Spain, Carotid Artery Stents, Market Forecast, 2004-2011

Exhibit 3-74: United Kingdom, Carotid Artery Stents, Market Forecast, 2004-2011

Exhibit 3-75: Benelux Countries, Carotid Artery Stents, Market Forecast, 2004-2011

Exhibit 3-76: Nordic Countries, Carotid Artery Stents, Market Forecast, 2004-2011

Exhibit 3-77: Rest-of-Europe, Carotid Artery Stents, Market Forecast, 2004-2011

Exhibit 3-78: 2004, Europe, Carotid Artery Stents Market, Share by Supplier

4. COMPETITIVE TECHNOLOGIES

4.1 Endovascular Brachytherapy

4.1.1 Technology

4.1.2 Isotopes

4.1.3 Delivery Systems

4.1.3.1 Gas-Filled Balloons

4.1.3.2 Liquid-Filled Balloons

4.1.3.3 Radioactive Stents

4.1.3.4 Seeds

4.1.3.5 Wires

4.1.4 Advantages and Disadvantages

4.1.5 Clinical Trials

4.2 Photodynamic Therapy

4.2.1 Technology

4.2.2 Products

4.3 Therapeutic Angiogenesis

4.3.1 Technology

4.3.2 Clinical Trials

4.4 Therapeutic Apheresis

4.4.1 Technology

4.4.2 Products

4.5 Statins

4.5.1 Technology

4.5.2 Products

Exhibit 4-1: 2004, Number of Brachytherapy Facilities in Europe

Exhibit 4-2: 2005, Selected Radionuclides Used in Endovascular Brachytherapy

Exhibit 4-3: Summary of Clinical Trials for the Study of Endovascular Brachytherapy in Femoropopliteal Restenosis Prevention

Exhibit 4-4: Growth Factors That Promote Angiogenesis

Exhibit 4-5: Clinical Trials for the Study of Therapeutic Angiogenesis

Exhibit 4-6: 2005, Comparison of Currently Available Statins

5. COMPANY PROFILES

5.1 Abbott Laboratories

5.2 amg International GmbH

5.3 C.R. Bard, Inc.

5.4 BIOTRONIK GmbH & Co.

5.5 Boston Scientific Corporation

5.6 ClearStream Technologies Group PLC

5.7 Cook Group

5.8 Cordis Corporation/Johnson & Johnson

5.9 ELLA-CS

5.10 ev3, Inc.

5.11 W.L. Gore & Associates, Inc.

5.12 Guidant Corporation

5.13 Medtronic, Inc.

5.14 Sorin Biomedica Cardio SPA/Sorin Group SPA



COMPANIES COVERED:

  1. Abbott Laboratories
  2. amg International GmbH
  3. Amylin Pharmaceuticals, Inc.
  4. AnGes MG, Inc.
  5. Angiomed GmbH & Company
  6. Angiotech Pharmaceuticals, Inc.
  7. ARIAD Pharmaceuticals, Inc.
  8. AstraZeneca AB
  9. AstraZeneca Pharmaceuticals LP
  10. Aventis Pharmaceuticals, Inc.
  11. Axcan Pharma, Inc.
  12. C. R. Bard, Inc.
  13. Bayer Corporation
  14. Biocompatibles International PLC
  15. Biosensors International Group LTD
  16. BIOTRONIK GmbH & Company
  17. Biovail Corporation
  18. Biovail Pharmaceuticals, Inc.
  19. Blue Medical Devices BV
  20. Boehringer Ingelheim GmbH
  21. Boston Scientific Corporation
  22. Bristol-Myers Squibb Company
  23. CardioTech International, Inc.
  24. Celltech Group PLC
  25. Centocor, Inc.
  26. Chiron Corporation
  27. ClearStream Technologies LTD
  28. Collateral Therapeutics, Inc.
  29. Conor Medsystems, Inc.
  30. Cook Group, Inc.
  31. Cordis Corporation
  32. CryoVascular Systems, Inc.
  33. Diomed, Inc.
  34. Edwards Lifesciences Corporation
  35. ELLA-CS
  36. Endologix, Inc.
  37. EndoTex Interventional Systems, Inc.
  38. eucatech AG
  39. ev3 Europe SAS
  40. ev3, Inc.
  41. Fresenius AG
  42. Genentech, Inc.
  43. GenVec, Inc.
  44. Genzyme Corporation
  45. GlaxoSmithKline PLC
  46. W.L. Gore & Associates, Inc.
  47. Guidant Corporation
  48. HEXACATH
  49. Implant Sciences Corporation
  50. InFlow Dynamics AG
  51. Invatec SRL
  52. Johnson & Johnson
  53. Kaneka Pharma NV
  54. Kos Pharmaceuticals, Inc.
  55. Lumenis LTD
  56. Medinol LTD
  57. Medtronic AVE, Inc.
  58. Medtronic, Inc.
  59. Medtronic Europe Sarl
  60. Merck & Company, Inc.
  61. Micro Therapeutics, Inc.
  62. Miltenyi Biotec GbmH
  63. Minvasys
  64. Miravant Medical Technologies
  65. MIV Therapeutics, Inc.
  66. Monarch Pharmaceuticals, Inc.
  67. Novartis AG
  68. Novartis Pharmaceuticals Corporation
  69. Novartis Pharma GmbH
  70. Novoste Corporation
  71. NuMED Canada, Inc.
  72. Occam International BV
  73. Oncura
  74. Pfizer, Inc.
  75. Possis Medical, Inc.
  76. QLT, Inc.
  77. Roche Pharmaceuticals, Inc.
  78. Rubicon Medical, Inc.
  79. Sahajanand Medical Technologies PVT LTD
  80. Sankyo Pharma, Inc.
  81. Sanofi-Aventis Group
  82. Schwarz Pharma AG
  83. Solvay Pharmaceuticals, Inc.
  84. Solvay SA
  85. Sorin Biomedica Cardio SPA
  86. St. Jude Medical, Inc.
  87. SurModics, Inc.
  88. Terumo Europe NV
  89. Translumina GmbH
  90. Vascular Solutions, Inc.
  91. Vascular Solutions GmbH
  92. Wyeth Pharmaceuticals
Contact Us

Need help finding medtech research? Let us help you!